Brenda M Sandmaier (Brenda Sandmaier)

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 27

Top Topics

Stem Cell Transplantation

Mild Traumatic Brain Injury

Top Venues

Bone marrow transplantation

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Florent Malard, Ernst Holler, Brenda M Sandmaier, He Huang, Mohamad Mohty
Acute graft-versus-host disease. Nature reviews. Disease primers 9 (1) (2023)
Lambros Kordelas, Tobias Terzer, Ted A Gooley, Chris Davis, Brenda M Sandmaier, Mohamed Lotfy Sorror, Olaf Penack, Nigel Dross Engelbert Schaeper, Igor W Blau, Dietrich W Beelen, Aleksandar Radujkovic, Peter Dreger, Thomas Luft
EASIX-1 year and late mortality after allogeneic stem cell transplantation. Blood advances (2023)
Garrett A Perchetti, Melinda A Biernacki, Hu Xie, Jared Castor, Laurel Joncas-Schronce, Masumi Ueda Oshima, YoungJun Kim, Keith R Jerome, Brenda M Sandmaier, Paul J Martin, Michael Boeckh, Alexander L Greninger, Danniel Zamora
Cytomegalovirus breakthrough and resistance during letermovir prophylaxis. Bone marrow transplantation (2023)
Masumi Ueda Oshima, Hu Xie, Danniel Zamora, Mary E Flowers, Geoffrey R Hill, Marco Mielcarek, Brenda M Sandmaier, Theodore A Gooley, Michael J Boeckh
Impact of GVHD prophylaxis on CMV reactivation and disease after HLA-matched peripheral blood stem cell transplantation. Blood advances (2023)
Johnnie J Orozco, Phuong T Vo, Theodore A Gooley, Robyn L Haaf, Sally J Lundberg, Donald K Hamlinn, D Scott Wilbur, Manuela C Matesan, Darrell R Fisher, Ajay K Gopal, Damian J Green, John M Pagel, Brenda M Sandmaier
Targeted Radiation Delivery Before Haploidentical HCT for High-risk Leukemia or MDS Patients Yields Long-Term Survivors. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
George S Laszlo, Johnnie J Orozco, Allie R Kehret, Margaret C Lunn, Jenny Huo, Donald K Hamlin, D Scott Wilbur, Shannon L Dexter, Melissa L Comstock, Shyril O'Steen, Brenda M Sandmaier, Damian J Green, Roland Bruno Walter
Development of [ 211 At]astatine-based anti-CD123 radioimmunotherapy for acute leukemias and other CD123+ malignancies. Leukemia 36 (6) (2022)
Roland Bruno Walter, Brenda M Sandmaier, Megan K D Othus, Corentin Orvain, Eduardo Rodríguez-Arbolí, Masumi Ueda Oshima, Gary Schoch, Chris Davis, H Joachim Deeg, Rainer F Storb
Comparison of reduced intensity and nonmyeloablative conditioning for adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation in first or second remission. Bone marrow transplantation (2022)
Gabrielle Paras, Linde M Morsink, Megan Othus, Filippo Milano, Brenda M Sandmaier, Lucas C Zarling, Raffaele Palmieri, Gary Schoch, Chris Davis, Marie Bleakley, Mary E D Flowers, H Joachim Deeg, Frederick R Appelbaum, Rainer F Storb, Roland Bruno Walter
Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML. Blood 139 (11) (2022)
Sandi L Navarro, Zihan Zheng, Timothy W Randolph, Ryotaro Nakamura, Brenda M Sandmaier, David Hockenbery, Jeannine S McCune
Lipidomics of cyclophosphamide 4-hydroxylation in patients receiving post-transplant cyclophosphamide. Clinical and translational science 15 (11) (2022)
Lucas C Zarling, Megan K D Othus, Brenda M Sandmaier, Filippo Milano, Gary Schoch, Chris Davis, Marie Bleakley, H Joachim Deeg, Frederick R Appelbaum, Rainer F Storb, Roland Bruno Walter
Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation. Leukemia 36 (6) (2022)
Ahona Mukherjee, Ted Gooley, Marco Mielcarek, Brenda M Sandmaier, Kris Doney, Masumi Ueda Oshima, Leona Holmberg, K Scott Baker, Rachel B Salit, Elizabeth F Krakow, Kathleen Shannon-Dorcy, Chris Davis, Stephanie J Lee
Outcomes after hematopoietic cell transplantation among non-English- compared to English-speaking recipients. Bone marrow transplantation 57 (3) (2022)
Roland Bruno Walter, Brenda M Sandmaier, Megan K D Othus, Corentin Orvain, Eduardo Rodríguez-Arbolí, Masumi Ueda Oshima, Gary Schoch, Chris Davis, H Joachim Deeg, Rainer F Storb
Comparison of reduced intensity and nonmyeloablative conditioning for adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation in first or second remission. Bone marrow transplantation (2022)
Mohamed Lotfy Sorror, Ted A Gooley, Barry E Storer, Aaron T Gerds, Mikkael A Sekeres, Bruno C Medeiros, Eunice S Wang, Paul J Shami, Kehinde U A Adekola, Selina M Luger, Maria R Baer, David A Rizzieri, Tanya Wildes, Jamie Koprivnikar, Julie Smith, Mitchell Garrison, Kiarash Kojouri, Tammy A Schuler, Wendy M Leisenring, Lynn Onstad, Pamela S Becker, Stephanie J Lee, Brenda M Sandmaier, Frederick R Appelbaum, Elihu Estey, Jeannine McCune
An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm AML patients. Blood (2022)
Kamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, Mei-Jie Zhang, Khalid Bo-Subait, Jonathan Sanchez, Hai-Lin Wang, Mahmoud Aljurf, Amer Assal, Vera Ulrike Bacher, Sherif M Badawy, Nelli Bejanyan, Vijaya Raj Bhatt, Christopher N Bredeson, Michael Byrne, Paul Castillo, Jan Cerny, Saurabh Chhabra, Stefan Octavian Ciurea, Zachariah DeFilipp, Nosha Farhadfar, Shahinaz M Gadalla, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael Richard Grunwald, Shahrukh K. Hashmi, Gerhard Carl Hildebrandt, Christopher G Kanakry, Ankit Kansagra, Farhad Khimani, Maxwell M Krem, Hillard M Lazarus, Hongtao Liu, Rodrigo Martino Bofarull, Fotios V Michelis, Sunita Nathan, Taiga Nishihori, Richard F Olsson, Ran Reshef, David A Rizzieri, Jacob M Rowe, Bipin P Savani, Sachiko Seo, Akshay Sharma, Melhem Solh, Celalettin Ustun, Leo F Verdonck, Christopher S Hourigan, Brenda M Sandmaier, Mark R Litzow, Partow Kebriaei, Daniel J Weisdorf, Yanming Zhang, Martin S Tallman, Wael Saber
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood advances (2021)
Mary-Elizabeth M Percival, Hai-Lin Wang, Mei-Jie Zhang, Wael Saber, Marcos J deLima, Mark Litzow, Partow Kebriaei, Hisham Abdel-Azim, Kehinde Adekola, Mahmoud Aljurf, Ulrike Bacher, Sherif M Badawy, Amer Beitinjaneh, Nelli Bejanyan, Vijaya Raj Bhatt, Michael Byrne, Jean-Yves Cahn, Paul Castillo, Nelson Chao, Saurabh Chhabra, Edward Copelan, Corey Cutler, Zachariah DeFilipp, Ajoy Dias, Miguel Angel Diaz, Elihu Estey, Nosha Farhadfar, Haydar A Frangoul, César O Freytes, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael R Grunwald, Nasheed M Hossain, Rammurti T Kamble, Christopher G Kanakry, Ankit Kansagra, Mohamed A Kharfan-Dabaja, Maxwell Krem, Hillard M Lazarus, Jong Wook Lee, Jane L Liesveld, Richard J Lin, Hongtao Liu, Joseph P McGuirk, Reinhold Munker, Hemant S Murthy, Sunita Nathan, Taiga Nishihori, Richard F Olsson, Neil Palmisiano, Jakob R Passweg, Tim Prestidge, Olle Ringdén, David A Rizzieri, Witold B Rybka, Mary Lynn Savoie, Kirk R Schultz, Sachiko Seo, Akshay Sharma, Melham M Solh, Roger Strair, Marjolein van der Poel, Leo F Verdonck, Jean A Yared, Daniel J Weisdorf, Brenda M Sandmaier
Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation. Bone marrow transplantation 56 (9) (2021)
Victor A Chow, Ryan D Cassaday, Theodore A Gooley, Stephen Douglas Smith, Brenda M Sandmaier, Damian J Green, Johnnie J Orozco, Sherilyn A Tuazon, Manuela Matesan, Darrell R Fisher, David G Maloney, Oliver W Press, Ajay K Gopal
Mega-dose 90Y-Ibritumomab tiuxetan prior to allogeneic transplantation is effective for aggressive large B-cell lymphoma. Blood advances (2021)
Matthew J Wieduwilt, Wendy Stock, Anjali S Advani, Selina M Luger, Richard A Larson, Martin Tallman, Frederick Appelbaum, Mei-Jie Zhang, Khalid Bo-Subait, Hai-Lin Wang, Vijaya Raj Bhatt, Bhagirathbhai R Dholaria, Mary Eapen, Mehdi Hamadani, Omer Jamy, Tim Prestidge, Michael A Pulsipher, David Ritchie, David Rizzieri, Akshay Sharma, Pere Barba, Brenda M Sandmaier, Marcos J deLima, Partow Kebriaei, Mark R Litzow, Wael Saber, Daniel J Weisdorf
Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR. Leukemia 35 (7) (2021)
Mohamed Lotfy Sorror, Barry E Storer, Amir T Fathi, Andrew Brunner, Aaron T Gerds, Mikkael A Sekeres, Sudipto Mukherjee, Bruno C Medeiros, Eunice S Wang, Pankit Vachhani, Paul J Shami, Esteban Peña, Mahmoud Elsawy, Kehinde U A Adekola, Selina Luger, Maria R Baer, David A Rizzieri, Tanya M Wildes, Jamie Koprivnikar, Julie Smith, Mitchell Garrison, Kiarash Kojouri, Wendy M Leisenring, Lynn Onstad, Jennifer E Nyland, Pamela S Becker, Jeannine S McCune, Stephanie J Lee, Brenda M Sandmaier, Frederick R Appelbaum, Elihu H Estey
Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia. Blood 138 (5) (2021)
Michael J Hochman, Megan Othus, Roland B Walter, Carole Shaw, Kelda Gardner, Mary-Elizabeth M Percival, Anna B Halpern, Paul C Hendrie, Brenda M Sandmaier, Elihu H Estey
Effect of post-treatment MRD status on subsequent outcomes according to chemotherapy intensity in acute myeloid leukemia (AML). Leukemia & lymphoma 62 (6) (2021)
Johnnie J Orozco, Aimee L Kenoyer, Yukang Lin, Shyril O'Steen, Rosario Guel, Margaret E Nartea, Alexandra H Hernandez, Mark D Hylarides, Darrell R Fisher, Ethan R Balkin, Donald K Hamlin, D Scott Wilbur, Kelly D Orcutt, K Dane Wittrup, Damian J Green, Ajay K Gopal, Brian G Till, Brenda M Sandmaier, Oliver W Press, John M Pagel
Therapy of Myeloid Leukemia using Novel Bispecific Fusion Proteins Targeting CD45 and 90Y-DOTA. Molecular cancer therapeutics 19 (12) (2020)
Armin Rashidi, Mehdi Hamadani, Mei-Jie Zhang, Hai-Lin Wang, Hisham Abdel-Azim, Mahmoud Aljurf, Amer Assal, Ashish Bajel, Asad Bashey, Minoo Battiwalla, Amer M Beitinjaneh, Nelli Bejanyan, Vijaya Raj Bhatt, Javier Bolaños-Meade, Michael Byrne, Jean-Yves Cahn, Mitchell Cairo, Stefan Ciurea, Edward Copelan, Corey Cutler, Andrew Daly, Miguel-Angel Diaz, Nosha Farhadfar, Robert Peter Gale, Siddhartha Ganguly, Michael R Grunwald, Theresa Hahn, Shahrukh K. Hashmi, Gerhard Carl Hildebrandt, H Kent Holland, Nasheed Hossain, Christopher G Kanakry, Mohamed A Kharfan-Dabaja, Nandita Khera, Yener Koc, Hillard M Lazarus, Jong-Wook Lee, Johan Maertens, Rodrigo Martino, Joseph P McGuirk, Reinhold Munker, Hemant S Murthy, Ryotaro Nakamura, Sunita Nathan, Taiga Nishihori, Neil Palmisiano, Sagar S Patel, Joseph Pidala, Rebecca Olin, Richard F Olsson, Betul Oran, Olle Ringdén, David Rizzieri, Jacob Rowe, Mary Lynn Savoie, Kirk R Schultz, Sachiko Seo, Brian C Shaffer, Anurag Singh, Melhem Solh, Keith Stockerl-Goldstein, Leo F Verdonck, John L Wagner, Edmund K Waller, Marcos De Lima, Brenda M Sandmaier, Mark R Litzow, Daniel J Weisdorf, Rizwan Romee, Wael Saber
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission. Blood advances 3 (12) (2020)
Elizabeth F Krakow, Boglarka Gyurkocza, Barry E Storer, Thomas R Chauncey, Jeannine S McCune, Jerald P Radich, Michelle E Bouvier, Elihu H Estey, Rainer Storb, David G Maloney, Brenda M Sandmaier
Phase I/II multisite trial of optimally dosed clofarabine and low-dose TBI for hematopoietic cell transplantation in acute myeloid leukemia. American journal of hematology 95 (1) (2019)
Kevin Scott Baker, Wendy M Leisenring, Pamela J Goodman, Ralph P Ermoian, Mary E Flowers, G Schoch, Rainer F Storb, Brenda M Sandmaier, H Joachim Deeg
Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation. Blood 133 (26) (2019)
Ryan D Cassaday, Philip A Stevenson, Brent L Wood, Pamela S Becker, Paul C Hendrie, Brenda M Sandmaier, Jerald L Radich, Andrei R Shustov
Description and prognostic significance of the kinetics of minimal residual disease status in adults with acute lymphoblastic leukemia treated with HyperCVAD. American journal of hematology 93 (4) (2018)
Damian J Green, David G Maloney, Barry E Storer, Brenda M Sandmaier, Leona A Holmberg, Pamela S Becker, Min Fang, Paul J Martin, George E Georges, Michelle E Bouvier, Rainer F Storb, Marco B Mielcarek
Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma. Blood advances 1 (24) (2017)
Brenda M Sandmaier, Samer Khaled, Betül Oran, Guy Gammon, Denise Trone, Olga Frankfurt
Results of a phase 1 study of quizartinib as maintenance therapy in subjects with acute myeloid leukemia in remission following allogeneic hematopoietic stem cell transplant. American journal of hematology 93 (2) (2017)
Damian J Green, Mazyar Shadman, Jon C Jones, Shani L Frayo, Aimee L Kenoyer, Mark D Hylarides, Donald K Hamlin, D Scott Wilbur, Ethan R Balkin, Yukang Lin, Brian W Miller, Sofia H L Frost, Ajay K Gopal, Johnnie J Orozco, Theodore A Gooley, Kelly L Laird, Brian G Till, Tom A Bäck, Brenda M Sandmaier, John M Pagel, Oliver W Press
Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model. Blood 125 (13) (2015)
Mohamed Lotfy Sorror, Paul J Martin, Rainer F Storb, Shailender Bhatia, Richard T Maziarz, Michael A Pulsipher, Michael B Maris, Christopher Davis, H Joachim Deeg, Stephanie J Lee, David G Maloney, Brenda M Sandmaier, Frederick R Appelbaum, Theodore A Gooley
Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality. Blood 124 (2) (2014)
Boglarka Gyurkocza, Brenda M Sandmaier
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all. Blood 124 (3) (2014)
Yoshihiro Inamoto, Mary Evelyn Flowers, Brenda M Sandmaier, Sahika Z Aki, Paul A Carpenter, Stephanie J Lee, Barry E Storer, Paul J Martin
Failure-free survival after initial systemic treatment of chronic graft-versus-host disease. Blood 124 (8) (2014)